TrialRespirology (Carlton, Vic.)2022

Efficacy of single-dose and double-dose ivermectin early treatment in preventing progression to hospitalization in mild COVID-19: A multi-arm, parallel-group randomized, double-blind, placebo-controlled trial.

Alireza Mirahmadizadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.